World's Best Scientists 2026 revealed!
Award Badge
Immunology
China
2026

D-Index & Metrics

Immunology

D-Index
102
Citations
56823
World Ranking
657
National Ranking
6

Medicine

D-Index
102
Citations
56850
World Ranking
7513
National Ranking
85

Yufang Shi publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Yufang Shi sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 305 publications — 65th percentile

65% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Yufang Shi D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Yufang Shi sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 102 D-Index — 87th percentile

87% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Immunology in China Leader Award
  • 2025 - Research.com Immunology in China Leader Award
  • 2023 - Research.com Immunology in China Leader Award
  • 2022 - Research.com Immunology in China Leader Award

Overview

Yufang Shi is affiliated with Soochow University in China. Their research spans multiple fields within medicine and molecular biology, with a focus on immunology, oncology, genetics, and cancer research.

The scientist has contributed to the understanding of mesenchymal stem cells and immune responses, with a notable emphasis on COVID-19 related studies. Their research covers key topics including:

  • Mesenchymal stem cell research
  • Immune cells in cancer
  • COVID-19 Clinical Research Studies
  • Cancer Cells and Metastasis
  • Cancer Immunotherapy and Biomarkers
  • Epigenetics and DNA Methylation
  • SARS-CoV-2 and COVID-19 Research

Yufang Shi has published in several prominent venues, primarily those specializing in cell death and disease mechanisms. The frequent publication venues include:

  • Cell Death and Disease
  • Cell Death and Differentiation
  • Cell Death Discovery
  • Biology Direct
  • Cytotherapy

Some recent representative papers by Yufang Shi are:

  • COVID-19 infection: the perspectives on immune responses, 2020, Cell Death and Differentiation
  • The secretion profile of mesenchymal stem cells and potential applications in treating human diseases, 2022, Signal Transduction and Targeted Therapy
  • Reciprocal regulation of mesenchymal stem cells and immune responses, 2022, Cell Stem Cell
  • Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19), 2020, Cell Death and Differentiation
  • Macrophage polarization and metabolism in atherosclerosis, 2023, Cell Death and Disease

Their frequent co-authors include:

  • Gerry Melino
  • Ying Wang
  • Changshun Shao
  • Eleonora Candi
  • Jiankai Fang

Yufang Shi's extensive publication record reflects a multidisciplinary approach, integrating molecular biology, immunology, and cancer research with clinical studies, especially in the context of infectious diseases like COVID-19.

Best Publications

  • Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018

    Lorenzo Galluzzi;Ilio Vitale;Stuart A. Aaronson;John M. Abrams

  • Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012

    Galluzzi L;Vitale I;Vitale I;Vitale I;Abrams Jm;Alnemri Es

  • Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide.

    Guangwen Ren;Liying Zhang;Xin Zhao;Guangwu Xu

  • Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis

    Kurt Degenhardt;Robin Mathew;Robin Mathew;Brian Beaudoin;Brian Beaudoin;Kevin Bray

  • COVID-19 infection: the perspectives on immune responses.

    Yufang Shi;Ying Wang;Changshun Shao;Jianan Huang

  • Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications.

    Ying Wang;Xiaodong Chen;Wei Cao;Yufang Shi

  • Interleukin-10 and Related Cytokines and Receptors

    Sidney Pestka;Christopher D. Krause;Devanand Sarkar;Mark R. Walter

  • Fate decision of mesenchymal stem cells: adipocytes or osteoblasts?

    Q Chen;Q Chen;P Shou;C Zheng;M Jiang

  • Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases.

    Yufang Shi;Yufang Shi;Yu Wang;Qing Li;Keli Liu

  • Essential versus accessory aspects of cell death: recommendations of the NCCD 2015

    L. Galluzzi;J. M. Bravo-San Pedro;I. Vitale;S. A. Aaronson

  • Mesenchymal stem cells: a new trend for cell therapy

    Xin Wei;Xue Yang;Zhi-peng Han;Fang-fang Qu

  • Immunobiology of mesenchymal stem cells

    S Ma;N Xie;W Li;B Yuan

  • Mesenchymal stem cells derived from human gingiva are capable of immunomodulatory functions and ameliorate inflammation-related tissue destruction in experimental colitis

    Qunzhou Zhang;Shihong Shi;Yi Liu;Jettie Uyanne

  • Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas

    Yufang Shi;Jacqueline M. Glynn;Lawrence J. Guilbert;Thomas G. Cotter

  • Inflammatory Cytokine-Induced Intercellular Adhesion Molecule-1 and Vascular Cell Adhesion Molecule-1 in Mesenchymal Stem Cells Are Critical for Immunosuppression

    Guangwen Ren;Xin Zhao;Liying Zhang;Jimin Zhang

  • New horizons in tumor microenvironment biology: challenges and opportunities

    Fei Chen;Xueqian Zhuang;Liangyu Lin;Pengfei Yu

  • Mesenchymal stem versus stromal cells: International Society for Cell & Gene Therapy (ISCT®) Mesenchymal Stromal Cell committee position statement on nomenclature.

    S. Viswanathan;Y. Shi;Y. Shi;J. Galipeau;M. Krampera

  • How mesenchymal stem cells interact with tissue immune responses

    Yufang Shi;Juanjuan Su;Arthur I. Roberts;Peishun Shou

  • Species Variation in the Mechanisms of Mesenchymal Stem Cell‐Mediated Immunosuppression

    Guangwen Ren;Juanjuan Su;Juanjuan Su;Liying Zhang;Xin Zhao

  • Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair.

    Yufang Shi;Gangzheng Hu;Juanjuan Su;Wenzhao Li

  • The end of the (cell) line: methods for the study of apoptosis in vitro.

    Anne J. McGahon;Seamus J. Martin;Reid P. Bissonnette;Artin Mahboubi

Frequent Co-Authors

Ying Wang
Ying Wang Shanghai Jiao Tong University
Gerry Melino
Gerry Melino University of Rome Tor Vergata
Changshun Shao
Changshun Shao Soochow University
Douglas R. Green
Douglas R. Green St. Jude Children's Research Hospital
Arnold B. Rabson
Arnold B. Rabson Rutgers, The State University of New Jersey
Mauro Piacentini
Mauro Piacentini University of Rome Tor Vergata
Gordon B. Mills
Gordon B. Mills Oregon Health & Science University
Eleonora Candi
Eleonora Candi University of Rome Tor Vergata
Oliver Kepp
Oliver Kepp Institut Gustave Roussy
Jacques Galipeau
Jacques Galipeau University of Wisconsin–Madison

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in immunology often intersects with various healthcare fields, especially nursing. For those interested in entering nursing from a non-nursing background, exploring the best online BSN programs for non nurses can provide a flexible and effective way to gain essential clinical knowledge and skills.

If you’re seeking a quicker entry into the nursing profession, consider ABSN programs with high acceptance rates. These accelerated paths are designed for students who already hold a degree in another field, offering intensive coursework and practical experience in a shorter time frame.

For individuals looking for accessible, entry-level nursing credentials, LPN schools easy to get into provide an excellent starting point. Licensed Practical Nurses can work alongside immunologists in clinical settings, gaining valuable hands-on experience.

Advancing your nursing career with specialized skills is also possible through some of the easiest nurse practitioner program options. These programs allow RNs to deepen their expertise and take on expanded roles that often collaborate with immunology research and patient care.

Best Scientists Citing Yufang Shi

Trending Scientists

Recently Published Articles